Cyberdyne Inc
Cyberdyne Inc develops and commercializes advanced medical equipment and technology, primarily focused on robotic exoskeletons and assistive devices for healthcare applications.
Business. Cyberdyne Inc is a Japanese company engaged in the Advanced Medical Equipment & Technology industry, primarily operating through a product-sale revenue model. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange under the ticker symbol 7779.T. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Cyberdyne Inc is a Japanese company engaged in the Advanced Medical Equipment & Technology industry, primarily operating through a product-sale revenue model. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange under the ticker symbol 7779.T. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Cyberdyne Inc's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage profile. The company holds significant liquidity with JPY 6.824 billion in cash and equivalents, which is 14.88% of total assets. However, negative operating and free cash flows of JPY -430 million and JPY -339 million, respectively, suggest ongoing cash burn despite strong asset base.
Profitability metrics are negative, with a return on equity of -1.46% and a return on assets of -1.19%, both well below the industry median for advanced medical equipment firms. The company reported a net loss of JPY 576 million for the period, driven by an operating loss of JPY 609 million. These results indicate a need for operational restructuring or product innovation to restore profitability.
Geographically, Cyberdyne Inc's revenue is concentrated in Japan, with no disclosed international segments in the latest financials. The company's business model is heavily dependent on domestic healthcare demand and regulatory approvals, which increases exposure to local economic and policy shifts.
Growth trajectory is currently negative, with declining operating income and net income. The company's capital expenditures of JPY -305 million suggest ongoing investment in infrastructure, but this has not yet translated into improved profitability. Management will need to demonstrate a clear path to positive cash flow generation to attract long-term investors.
Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative cash flows and operating losses could become a concern if not addressed. There is no evidence of near-term dilution pressure, with basic and diluted shares outstanding aligned at 133.43 million.
Recent filings and transcripts have not disclosed any material events that would significantly alter the company's risk profile. Investors should monitor the company's ability to reduce losses and improve cash flow generation in the coming quarters.
- Cyberdyne Inc is operating at a net loss with negative cash flows, indicating a need for operational improvements.
- The company maintains a strong liquidity position with JPY 6.824 billion in cash and equivalents.
- Low debt-to-equity ratio of 0.01 suggests a conservative capital structure.
- Negative return on equity and return on assets highlight poor profitability.
- Revenue concentration in Japan increases exposure to local market risks.
- No immediate liquidity or dilution risks are currently flagged.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Cyberdyne Inc Market data — financials · 2026-05-27